James B. Thomas - Concepedia

Author

James B. Thomas

Also Known As

J B Thomas, J Thomas, J. B. THOMAS, J. Conley Thomas, J. Thomas, J.B. Thomas, James B Thomas, James B. Thomas, James Thomas, Thomas, James B.

Publications

Citations

H-Index

Concepts

All Affiliations

RTI International Eli Lilly (United States)Research Triangle Park Foundation University of North Carolina at Chapel Hill Duke University Hospital

About

James B. Thomas is an author at RTI International specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	683
2	Engineering	5	5	148
3	Health Sciences	4	4	149
4	Education	1	1	549
5	Management	1	1	549

James B. Thomas

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Efficacy-Performance Spirals: A Multilevel Perspective D. Lindsley, Daniel J. Brass, James B. Thomas Academy of Management Review Performance ManagementSelf-efficacy TheoryPerformance StudiesManagementOutcomes Research	1995	549
A-803467, a potent and selective Na <sub>v</sub> 1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat Michael F. Jarvis, Prisca Honoré, Char‐Chang Shieh, Proceedings of the National Academy of Sciences	2007	514
Anxiolytic-Like Effects of κ-Opioid Receptor Antagonists in Models of Unlearned and Learned Fear in Rats Allison T. Knoll, Edward G. Meloni, James B. Thomas, Journal of Pharmacology and Experimental Therapeutics	2007	226
Pharmacological properties of JDTic: a novel κ-opioid receptor antagonist Ivy Carroll, James B. Thomas, Linda Dykstra, European Journal of Pharmacology Molecular PharmacologyMedicinePharmacological PropertiesMechanism Of ActionPharmacological Agent	2004	122
The Total Synthesis of (±)-Ginkgolide B Michael T. Crimmins, Jennifer M. Pace, Philippe G. Nantermet, Journal of the American Chemical Society Medicinal ChemistryGinkgolide BBioorganic ChemistryHeterocyclicBiochemistry	2000	105
Identification of the First <i>trans</i>-(3<i>R</i>,4<i>R</i>)- Dimethyl-4-(3-hydroxyphenyl)piperidine Derivative To Possess Highly Potent and Selective Opioid κ Receptor Antagonist Activity James B. Thomas, Robert N. Atkinson, Richard B. Rothman, Journal of Medicinal Chemistry	2001	105
Discovery and Biological Evaluation of 5-Aryl-2-furfuramides, Potent and Selective Blockers of the Na<sub>v</sub>1.8 Sodium Channel with Efficacy in Models of Neuropathic and Inflammatory Pain Michael E. Kort, Irene Drizin, Robert J. Gregg, Journal of Medicinal Chemistry Pain DisordersPain MedicineNeuropathic PainMolecular PainPharmacotherapy	2008	83
Identification of (3<i>R</i>)-7-Hydroxy-<i>N</i>-((1<i>S</i>)-1-{[(3<i>R</i>,4<i>R</i>)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a Novel Potent and Selective Opioid κ Receptor Antagonist James B. Thomas, Robert N. Atkinson, N. Ariane Vinson, Journal of Medicinal Chemistry	2003	75
Identification of an Opioid κ Receptor Subtype-Selective N-Substituent for (+)-(3<i>R</i>,4<i>R</i>)-Dimethyl-4-(3-hydroxyphenyl)piperidine James B. Thomas, Michael J. Fall, Julie Cooper, Journal of Medicinal Chemistry	1998	53
Total Synthesis of (±)-Ginkgolide B Michael T. Crimmins, Jennifer M. Pace, Philippe G. Nantermet, Journal of the American Chemical Society	1999	53

Page 1